Literature DB >> 31014047

[Current status of prognostic evaluation of esophageal cancer patients by circumferential resection margin].

L G Yuan1, Y S Mao.   

Abstract

Esophageal cancer is the sixth leading cause of cancer-related death worldwide due to its high malignancy and poor prognosis. In recent decades, the applications of new technologies, devices and neoadjuvant therapy lead to the great progress in the diagnosis and treatment of esophageal cancer. However, the five-year survival rate of esophageal cancer remains unsatisfied. Clinical and pathological factors such as the primary tumor (T), regional lymph nodes (N) and distant metastasis (M) and the longitudinal margins of esophageal lesions, lymphatic invasion, peripheral nerve invasion have been identified as important predictors of the prognosis of esophageal cancer. However, the effect of circumferential resection margin on the prognosis evaluation of esophageal cancer is still controversial, and no definite identification of circumferential resection margin of esophageal cancer has been acknowledged worldwide. Therefore, the studies of circumferential resection margin involvement in predicting the prognosis of esophageal cancer are reviewed.

Entities:  

Keywords:  Circumferential resection margin; Esophageal neoplasms; Prognosis

Mesh:

Year:  2019        PMID: 31014047     DOI: 10.3760/cma.j.issn.0253-3766.2019.04.001

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

1.  Diagnosis of Nonperitonealized Colorectal Cancer with Computerized Tomography Image Features under Deep Learning.

Authors:  Xiaohong Wang; Changyi Guo; Yufeng Zha; Kai Xu; Xiaochao Liu
Journal:  Contrast Media Mol Imaging       Date:  2022-05-25       Impact factor: 3.009

2.  Survival outcomes for patients with four treatments in stages I-III esophageal squamous cell carcinoma: a SEER analysis.

Authors:  Jingyang Wu; Jiansheng Yang; Xianbin Lin; Liang'an Lin; Wentan Jiang; Chengke Xie
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.